Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 107, Iss. 2, 2002-03 ,pp. : 76-94

Karger

Access to resources Recommend Favorite

Continuous Complete Hematological and Cytogenetic Remission with Molecular Minimal Residual Disease 9 Years after Discontinuation of Interferon-α in a Patient with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Molecular monitoring of chronic myeloid leukemia: a personalized approach to optimizing treatment response

By Nichols Linda   Pippins Julie   Castle Lon   Cassler Mary   Fuller Courtney  

Personalized Medicine, Vol. 9, Iss. 7, 2012-09 ,pp. : 727-737

Future Medicine

Access to resources Recommend Favorite

Clofarabine-Based Regimen as Useful Bridge Therapy for Allogeneic Transplantation in Myeloid Blast Crisis of Philadelphia-Positive Chronic Myeloid Leukemia Resistant to Imatinib and Dasatinib

By  

Acta Haematologica, Vol. 124, Iss. 3, 2010-10 ,pp. : 150-152

Karger

Access to resources Recommend Favorite

Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-07 ,pp. : 6-10

Karger

Access to resources Recommend Favorite